|
1) |
Epstein JI, Steinberg GD. The significance of low-grade prostate cancer on needle biopsy. A radical prostatectomy study of tumor grade , volume, and stage of the biopsied and multifocal tumor. Cancer. 1990;66(9):1927-32. |
2) |
Ohori M, Goad JR, Wheeler TM, et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol. 1994;152(5 Pt 2):1843-9. |
3) |
Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage , and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 1997;277(18):1445-51. |
4) |
Gancarczyk KJ, Wu H, McLeod DG, et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy:the Center for Prostate Disease Research nomograms. Urology. 2003;61(3):589-95. |
5) |
Borque A, Sanz G, Allepuz C, et al. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy:a population based study. J Urol. 2001;166(5):1672-8. |
6) |
Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. Journal of the National Cancer Institute. 1998;90(10):766-71. |
7) |
Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2002;20(15):3206-12. |
8) |
Han M, Partin AW, Zahurak M, et al. Biochemical(prostate specific antigen)recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169(2):517-23. |
9) |
Penson DF, Grossfeld GD, Li YP, et al. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol. 2002;167(4):1653-7;discussion 1657-8. |
10) |
Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64. |
11) |
Yatani R, Chigusa I, Akazaki K, et al. Geographic pathology of latent prostatic carcinoma. Int J Cancer. 1982;29:611-6. |
12) |
Egawa S, Suyama K, Arai Y, et al. Treatment outcome by risk group after radical prostatectomy in Japanese men. Int J Urol. 2001;8(6):295-300. |